切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - constitutive androstane receptor (CAR) - Insulin-like growth factors (IGFs) - Ionophores - Topoisomerases

20件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. CITCO
    B7468 CITCO
     1 Citation
    Target: constitutive androstane receptor (CAR)
    Summary: 组成型雄激素受体(CAR)激动剂
      Soluble in DMSO
  3. Valinomycin
    B7388 Valinomycin
    中文名: 缬氨霉素
    Target: Ionophores
    Summary: 钾离子特异性转运体
      ≥51.1 mg/mL
      insoluble in H2O
  4. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  5. Sodium Monensin
    B3668 Sodium Monensin
    中文名: 莫能菌素钠盐
    Target: Ionophores
    Summary: 天然聚醚离子载体抗生素
      insoluble in DMSO
      insoluble in H2O
  6. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  7. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  8. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  9. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  10. AZD-3463
    A8620 AZD-3463
     3 Citation
    Target: ALK|Insulin-like growth factors (IGFs)
    Summary: ALK/IGF1R抑制剂
      ≥11.22 mg/mL
      insoluble in H2O

20件产品中的 1-10

页面
每页